Etomidate Dosing Recommendations
For induction of anesthesia in adults and pediatric patients above age 10, administer etomidate 0.2-0.6 mg/kg IV, with the usual dose being 0.3 mg/kg injected over 30-60 seconds 1.
Adult Dosing
Induction
- Standard dose: 0.3 mg/kg IV over 30-60 seconds 1
- Dose range: 0.2-0.6 mg/kg, individualized based on patient factors 2, 1
- Geriatric patients require reduced doses due to increased risk of hemodynamic changes including decreased heart rate, cardiac index, and mean arterial pressure 1
Maintenance (if used)
- Continuous infusion: 5-20 μg/kg/min 2
- Considered safe for procedures lasting <4 hours 2
- Can be used as supplemental boluses during short procedures (smaller than induction dose) 1
Pediatric Dosing
Children >10 years old
- 0.3-0.4 mg/kg IV for induction 1, 3
- Higher dose (0.4 mg/kg) may be needed due to larger volume of distribution and higher clearance compared to adults 3
- 0.2 mg/kg is inadequate in unpremedicated children 4
Children <10 years old
- Not recommended - insufficient data for safe dosing recommendations 1
Important Clinical Considerations
Hemodynamic Profile
Etomidate provides superior cardiovascular stability compared to other induction agents, with minimal changes in mean arterial pressure and heart rate in most patients 5, 6. However, hypertensive geriatric patients may experience significant hemodynamic depression 1.
Common Side Effects to Anticipate
- Pain on injection (27% incidence in children, common in adults) 4, 7
- Myoclonus (10% in children, high incidence in adults) 4, 7
- Adrenocortical suppression lasting 6-8 hours, unresponsive to ACTH 1, 8
Combination Therapy
When combined with alfentanil (100 μg/kg) or fentanyl (0.1 mg IV given 1-2 minutes before induction), less etomidate is typically required and immediate recovery is shortened 1, 6. Etomidate with alfentanil and rocuronium provides excellent intubation conditions with attenuated response to intubation 6.
Critical Care Context
Recent high-quality evidence from 2025 shows that in critically ill adults undergoing tracheal intubation, etomidate (compared to ketamine) resulted in similar 28-day mortality (29.1% vs 28.1%) but lower incidence of cardiovascular collapse during intubation (17.0% vs 22.1%) 9. This supports etomidate's role in hemodynamically unstable patients despite ongoing concerns about adrenal suppression.
Key Pitfall
Do not use etomidate in children under 10 years old - the FDA label explicitly states inadequate data for this population 1. The 30% higher dose requirement in children relates to pharmacokinetic differences (larger initial volume of distribution and higher clearance) 3.